Variant report
Variant | esv3400999 |
---|---|
Chromosome Location | chr6:13881864-13884220 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147040831 | chr6:13881885-13881886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138517215 | chr6:13881906-13881907 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114749798 | chr6:13881919-13881920 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558697700 | chr6:13881963-13881964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1204260 | chr6:13881964-13881965 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs540717898 | chr6:13881967-13881968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369488730 | chr6:13881998-13881999 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144100833 | chr6:13882040-13882041 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377093119 | chr6:13882074-13882075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1204261 | chr6:13882076-13882077 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs182233621 | chr6:13882077-13882078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563508899 | chr6:13882090-13882091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150702665 | chr6:13882091-13882092 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs58260924 | chr6:13882104-13882105 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1204262 | chr6:13882127-13882128 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs566081664 | chr6:13882130-13882131 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139861958 | chr6:13882141-13882142 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149411095 | chr6:13882153-13882154 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571410635 | chr6:13882171-13882172 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568457953 | chr6:13882178-13882179 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371248378 | chr6:13882197-13882198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184898341 | chr6:13882238-13882239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569829259 | chr6:13882277-13882278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565636714 | chr6:13882278-13882279 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1204263 | chr6:13882360-13882361 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs558683648 | chr6:13882363-13882364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs6459172 | chr6:13882393-13882394 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs541003030 | chr6:13882420-13882421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115088262 | chr6:13882458-13882459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190196203 | chr6:13882465-13882466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370058216 | chr6:13882469-13882470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573649435 | chr6:13882472-13882473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563648174 | chr6:13882488-13882489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6924039 | chr6:13882489-13882490 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs566848922 | chr6:13882514-13882515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369555306 | chr6:13882564-13882565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182410795 | chr6:13882567-13882568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187913190 | chr6:13882589-13882590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35485521 | chr6:13882592-13882593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370477134 | chr6:13882608-13882609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146424145 | chr6:13882694-13882695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373596829 | chr6:13882720-13882721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375657521 | chr6:13882724-13882725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377326142 | chr6:13882748-13882749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370380718 | chr6:13882788-13882789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs550093313 | chr6:13882807-13882808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs193182450 | chr6:13882854-13882855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538817134 | chr6:13882971-13882972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139837026 | chr6:13883013-13883014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374526263 | chr6:13883019-13883020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 16790693 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:13880200-13882600 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
2 | chr6:13880400-13882000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr6:13881000-13882400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr6:13881400-13882400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr6:13881400-13882600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr6:13881400-13882600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr6:13881600-13882200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr6:13881600-13882400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr6:13881600-13882600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr6:13881800-13882200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr6:13881800-13882400 | Enhancers | Placenta Amnion | Placenta Amnion |
12 | chr6:13882400-13884600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr6:13882600-13885000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr6:13884000-13886000 | Enhancers | Fetal Brain Male | brain |
15 | chr6:13884200-13885200 | Enhancers | K562 | blood |